Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM) — Stella

Recruiting

Back to Obesity trials

Trial locations(1 site)

United States

University of Missouri School of Medicine, Columbia, Missouri

Key details

Sponsor

Bettina Mittendorfer

Collaborators

National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrollment target

~60 participants

Started

August 2024

Primary completion

March 2028

Age range

18 Years – 70 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov